198 related articles for article (PubMed ID: 19035445)
1. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
Lim U; Freedman DM; Hollis BW; Horst RL; Purdue MP; Chatterjee N; Weinstein SJ; Morton LM; Schatzkin A; Virtamo J; Linet MS; Hartge P; Albanes D
Int J Cancer; 2009 Feb; 124(4):979-86. PubMed ID: 19035445
[TBL] [Abstract][Full Text] [Related]
2. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition.
Łuczyńska A; Kaaks R; Rohrmann S; Becker S; Linseisen J; Buijsse B; Overvad K; Trichopoulou A; Valanou E; Barmpitsioti A; Masala G; Agnoli C; Tumino R; Panico S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Vermeulen R; Weiderpass E; Brustad M; Skeie G; González CA; Jakszyn P; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Melin B; Johansson AS; Almquist M; Malm J; Khaw KT; Wareham N; Travis RC; Fedirko V; Romieu I; Jenab M; Gallo V; Riboli E; Vineis P; Nieters A
Am J Clin Nutr; 2013 Sep; 98(3):827-38. PubMed ID: 23885049
[TBL] [Abstract][Full Text] [Related]
3. Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Purdue MP; Freedman DM; Gapstur SM; Helzlsouer KJ; Laden F; Lim U; Maskarinec G; Rothman N; Shu XO; Stevens VL; Zeleniuch-Jacquotte A; Albanes D; Bertrand K; Weinstein SJ; Yu K; Irish L; Horst RL; Hoffman-Bolton J; Giovannucci EL; Kolonel LN; Snyder K; Willett W; Arslan AA; Hayes RB; Zheng W; Xiang YB; Hartge P
Am J Epidemiol; 2010 Jul; 172(1):58-69. PubMed ID: 20562184
[TBL] [Abstract][Full Text] [Related]
4. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.
Arem H; Weinstein SJ; Horst RL; Virtamo J; Yu K; Albanes D; Abnet CC
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1178-84. PubMed ID: 21527582
[TBL] [Abstract][Full Text] [Related]
6. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
[TBL] [Abstract][Full Text] [Related]
7. Serum vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Männistö S; Snyder K; Horst RL; Virtamo J; Albanes D
Cancer Res; 2010 Nov; 70(22):9218-23. PubMed ID: 20978193
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic circulating carotenoid levels and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort.
Ollberding NJ; Maskarinec G; Conroy SM; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Le Marchand L; Goodman MT; Hernandez BY; Henderson BE; Kolonel LN
Blood; 2012 Jun; 119(24):5817-23. PubMed ID: 22550343
[TBL] [Abstract][Full Text] [Related]
9. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
[TBL] [Abstract][Full Text] [Related]
10. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.
Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D
Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.
Fedirko V; Duarte-Salles T; Bamia C; Trichopoulou A; Aleksandrova K; Trichopoulos D; Trepo E; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Kvaskoff M; Kühn T; Lukanova A; Boeing H; Buijsse B; Klinaki E; Tsimakidi C; Naccarati A; Tagliabue G; Panico S; Tumino R; Palli D; Bueno-de-Mesquita HB; Siersema PD; Peters PH; Lund E; Brustad M; Olsen KS; Weiderpass E; Zamora-Ros R; Sánchez MJ; Ardanaz E; Amiano P; Navarro C; Quirós JR; Werner M; Sund M; Lindkvist B; Malm J; Travis RC; Khaw KT; Stepien M; Scalbert A; Romieu I; Lagiou P; Riboli E; Jenab M
Hepatology; 2014 Oct; 60(4):1222-30. PubMed ID: 24644045
[TBL] [Abstract][Full Text] [Related]
12. Serum high-density lipoprotein cholesterol and risk of non-hodgkin lymphoma.
Lim U; Gayles T; Katki HA; Stolzenberg-Solomon R; Weinstein SJ; Pietinen P; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2007 Jun; 67(11):5569-74. PubMed ID: 17522388
[TBL] [Abstract][Full Text] [Related]
13. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Stolzenberg-Solomon RZ; Jacobs EJ; Arslan AA; Qi D; Patel AV; Helzlsouer KJ; Weinstein SJ; McCullough ML; Purdue MP; Shu XO; Snyder K; Virtamo J; Wilkins LR; Yu K; Zeleniuch-Jacquotte A; Zheng W; Albanes D; Cai Q; Harvey C; Hayes R; Clipp S; Horst RL; Irish L; Koenig K; Le Marchand L; Kolonel LN
Am J Epidemiol; 2010 Jul; 172(1):81-93. PubMed ID: 20562185
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and risk of non-Hodgkin lymphoma: a meta-analysis.
Lu D; Chen J; Jin J
Cancer Causes Control; 2014 Nov; 25(11):1553-63. PubMed ID: 25148916
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.
Weinstein SJ; Yu K; Horst RL; Ashby J; Virtamo J; Albanes D
Am J Epidemiol; 2011 Mar; 173(5):499-508. PubMed ID: 21248311
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic serum tocopherol levels and the risk of non-hodgkin lymphoma: the multiethnic cohort.
Morimoto Y; Ollberding NJ; Cooney RV; Wilkens LR; Franke AA; Le Marchand L; Goodman MT; Hernandez BY; Kolonel LN; Maskarinec G
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2075-83. PubMed ID: 24045922
[TBL] [Abstract][Full Text] [Related]
19. Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women.
Liang G; Nan H; Qureshi AA; Han J
PLoS One; 2012; 7(4):e35211. PubMed ID: 22493740
[TBL] [Abstract][Full Text] [Related]
20. Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer.
Weinstein SJ; Mondul AM; Kopp W; Rager H; Virtamo J; Albanes D
Int J Cancer; 2013 Jun; 132(12):2940-7. PubMed ID: 23180681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
